adjuvant

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all adjuvant drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Toll-like receptor 4.

Targets

Toll-like receptor 4

Phase 3 pipeline (1)

Montanide ISA 51 VG · National Cancer Institute (NCI) · Oncology
Montanide ISA 51 VG is an adjuvant used to enhance the immune response to vaccines.

Phase 2 pipeline (1)

GSK Biologicals' AS01B adjuvant · GlaxoSmithKline · Vaccines
Stimulates Toll-like receptor 4 and MyD88-dependent signaling pathway